Lightlake Therapeutics Inc - New York City, NY 10022

Lightlake Therapeutics Inc is a business in New York City, NY.

Business Name: Lightlake Therapeutics Inc
Categorized In:
Address: 251 East 51st St Apartment 9c, New York City, NY 10022
Phone Number: (917) 273-3611
Contact Person: Roger Crystal
NAICS Code: 325412
SIC Code: 2834
Business Type: B2B & B2C
Founding Year: 2014
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $50.000 to $99.999
Share This Business:
Similar Businesses: Tonix Pharmaceuticals Inc - New York City, NY 10022
Krele LLC - New York City, NY 10022
Melinta Pharmaceuticals Inc - New York City, NY 10022
Aoi Pharma Inc - New York City, NY 10022
Niobe Ventures LLC - New York City, NY 10022
Ohr Pharmaceutical Inc - New York City, NY 10022
Stemline Therapeutics Inc - New York City, NY 10022
Bristol-Myers Squibb Company - New York City, NY 10022
Forest Laboratories Inc - New York City, NY 10022
Keryx Biopharmaceuticals Inc - New York City, NY 10022
Danube Pharmaceuticals Inc - New York City, NY 10022

Lightlake Therapeutics Inc, a stable growing company under , is being run by Roger Crystal. Since , their sales have been favorable and consistent at $50.000 to $99.999. Company location coordinates are: .

It can be reached by dialing (917) 273-3611, and you could get in touch with their sales team in 251 East 51st St Apartment 9c, New York City, New York NY 10022. Visit their website at: to know more about the company’s history, products and services, as well as frequently asked questions and privacy policies.

Special deals are also offered from time to time. Their professional and honest business transactions fortifies both consumers and businesses in their BOTH segments.

Their modest but solid single location houses 1 to 4 staff members. All are benefiting from the company’s generous programs and sound training solutions.

You can learn more by checking their classification codes: SIC – 2834 and NAIC – 325412. Call the hotline stated above for faster transaction and queries. Lightlake Therapeutics Inc would like to hear from you.